Chorwacja - chorwacki - HALMED (Agencija za lijekove i medicinske proizvode)

markomed d.o.o. trg braće radića 3 21000 split -

Chorwacja - chorwacki - HALMED (Agencija za lijekove i medicinske proizvode)

cardio medical zagreb d.o.o. utinjska 40 10000 zagreb -

Chorwacja - chorwacki - HALMED (Agencija za lijekove i medicinske proizvode)

sanyko d.o.o. banjavčićeva 11 10000 zagreb -

Chorwacja - chorwacki - HALMED (Agencija za lijekove i medicinske proizvode)

sanyko d.o.o. banjavčićeva 11 10000 zagreb -

Chorwacja - chorwacki - HALMED (Agencija za lijekove i medicinske proizvode)

sanyko d.o.o. banjavčićeva 11 10000 zagreb -

Chorwacja - chorwacki - HALMED (Agencija za lijekove i medicinske proizvode)

sanyko d.o.o. banjavčićeva 11 10000 zagreb -

Chorwacja - chorwacki - HALMED (Agencija za lijekove i medicinske proizvode)

cardio medical zagreb d.o.o. utinjska 40 10000 zagreb -

Bośnia i Hercegowina - chorwacki - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

medicopharmacia d.o.o. - emtricitabin, emtricitabin, Тенофовир disoproksil, rilpivirin, Тенофовир disoproksil - film tableta - 200 mg/1 tableta+ 25 mg/1 tableta+ 245 mg/1 tableta - 1 film tableta sadrži: 200 mg emtricitabin, 25 mg rilpivirin (u obliku rilpivirin hidrohlorida) i 245 mg tenofovir disoproksil (u obliku tenofovir disoproksil fumarata)

Bośnia i Hercegowina - chorwacki - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

medicopharmacia d.o.o. sarajevo - Софосбувир, velpatasvir - film tableta - 400 mg/1 tableta+ 100 mg/1 tableta - 1 film tableta sadrži: 400 mg sofosbuvira 100 mg velpatasvira

Unia Europejska - chorwacki - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateron acetat - prostatske neoplazme - endokrinska terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.